Akers Biosciences Signs Distribution Agreement for BreathScan OxiChek(TM)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. SPCX
2. LEVI
3. SBUX
4. NVDA
5. GOOGL
6. AAPL
7. SPY
8. APLD
9. ORCL
10. USO

Go back to Akers Biosciences Signs Distribution Agreement for BreathScan OxiChek(TM)

Akers Biosciences (AKER) Surges Amid First OxiChek Distribution Agreement

June 27, 2016 9:41 AM EDT

Akers Biosciences (NASDAQ: AKER) is surging 45% in early trade after the company announced it signed its first distribution agreement for BreathScan OxiChek" ("OxiChek") with Aero-Med, a division of Cardinal Health, a Fortune 500 health care services organization.

Developed by Akers Bio as part of the Akers Wellness line, OxiChek is the first disposable breath test to rapidly determine levels of oxidative stress in the body by measuring the levels of certain abundant free radicals. Frequent use of OxiChek may help health... More